Vertex to Present at the Barclays Global Healthcare Conference on March 11
March 06 2014 - 4:25PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that it will present at the Barclays Global Healthcare
Conference on Tuesday, March 11 at 8:00 a.m. ET.
The audio portion of the remarks will be accessible live through
Vertex’s website at www.vrtx.com in the “Investors” section under
the “Events and Presentations” link. To ensure a timely connection,
it is recommended that users register at least 15 minutes prior to
the scheduled webcast. A replay of the webcast will also be
archived on the company’s website for a period of two weeks
following the presentation.
About Vertex
Vertex is a global biotechnology company that aims to discover,
develop and commercialize innovative medicines so people with
serious diseases can lead better lives. Vertex scientists and our
collaborators are working on new medicines to cure or significantly
advance the treatment of cystic fibrosis, hepatitis C, rheumatoid
arthritis and other life-threatening diseases. In addition to our
clinical development programs, Vertex has more than a dozen ongoing
preclinical programs aimed at other serious and life-threatening
diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. For four years in a row, Science
magazine has named Vertex one of its Top Employers in the life
sciences. For additional information and the latest updates from
the company, please visit www.vrtx.com.
(VRTX-WEB)
Vertex Pharmaceuticals IncorporatedInvestors:Michael
Partridge, 617-341-6108orKelly Lewis, 617-961-7530
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024